南山智尚(300918.SZ):截至2024年1季度,公司在營業收入、淨利潤等方面較去年同期都有一定的增長
格隆匯5月13日丨南山智尚(300918.SZ)在投資者互動平台表示,公司以“高新技術和高附加值產品轉型”為突破口,在加快傳統業務板塊數字化轉型升級的同時,重點發展新型化纖材料領域,着力打造“羊毛面料服裝與新材料雙產業鏈互動”的發展格局,逐步打開第二成長曲線。截至2024年1季度,公司在營業收入、淨利潤等方面較去年同期都有一定的增長;公司3600噸超高分子量聚乙烯項目,已於2023年8月份全線投入運行,經過工藝調整、設備磨合與人員培訓,產品技術和質量穩定性都有了穩步提升,結合目前市場環境,在環境穩定後,預計能夠實現本年生產經營目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.